Abbott Laboratories (ABT) reports robust earnings growth and margin expansion, driven by medical devices, despite headwinds ...

Q2 2025 Results Conference Call July 17, 2025 9:00 AM ETCompany ParticipantsMichael Comilla - Vice President of ...

Live Updates Live Coverage Updates appear automatically as they are published. Still no earnings at 7:05 a.m. ET 7:04 am by ...

ABT earnings call for the period ending December 31, 2024. ... Abbott Laboratories (NYSE: ABT) Q4 2024 Earnings Call Jan 22, 2025, 9:30 a.m. ET. Contents: Prepared Remarks. Questions and Answers.

Barclays analyst Matt Miksic maintained an Overweight rating and increased the price target from $158 to $159 on April 17, ...

Detailed price information for Abbott Laboratories (ABT-N) from The Globe and Mail including charting and trades.

Abbott Laboratories reports earnings inline with expectations. Reported EPS is $1.19 EPS, expectations were $1.19. ... Welcome to Abbott’s Fourth Quarter 2023 Earnings Conference Call.

"Halfway through the year, we delivered high single-digit organic sales growth, double-digit EPS growth, significantly ...

Q2 2025 Earnings Call Transcript July 17, 2025 Abbott Laboratories reports earnings inline with expectations. Reported EPS is $1.26 EPS, expectations were $1.26. Operator: Good morning, and thank you ...

Abbott Laboratories beats earnings expectations. Reported EPS is $1.14, expectations were $1.1. Operator: Good morning, and thank you for standing by. Welcome to Abbott’s Third Quarter 2023 ...

The Motley Fool. DATE Thursday, July 17, 2025 at 9 a.m. ET CALL PARTICIPANTS Chairman and Chief Executive Officer — Robert ...

Abbott Laboratories (NYSE:ABT) Q2 2024 Earnings Conference Call July 18, 2024 9:00 AM ETCompany Participants. Robert Ford - Chief Executive Officer Phil Boudreau - Executive Vice President ...